Added to YB: 2018-10-24
Pitch date: 2018-10-24
NTGN:US [bullish]
BioNTech US Inc.
-47.97%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BioNTech US Inc. operates as a clinical-stage immuno-oncology company that develops neoantigen-targeted therapies for cancer.
Market Cap
$88.9M
Pitch Price
$5.90
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-1.14
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
BioNTech US, Inc. NTGN:US
A summary for this pitch has not been created yet.
Read full article (0 min)